Nancy Lin, MD

Closed portfolio with an early-phase archive tilt

According to ClinicalTrials.gov-derived indexes, Nancy Lin, MD sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).

4 total trials none currently recruiting 2 completed early-phase tilt upper quartile by trial count

Nancy Lin, MD: 4 sponsored US clinical trials, none currently recruiting.

Nancy Lin, MD sponsors 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 2 completed. 0 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Central Nervous System Metastases, with 1 trials.

Upper-quartile sponsor footprint

Nancy Lin, MD sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Indexed trials (enrollment closed)

4 total, page 1 of 1

ACTIVE NOT RECRUITING Phase 2

Atezolizumab + Pertuzumab + Trastuzumab In CNS Mets In BC

NCT03417544
TERMINATED Phase 2

ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain Metastases

NCT00496379
COMPLETED Phase 2

Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive, Metastatic Breast Cancer

NCT00470704
COMPLETED Phase 1

Lapatinib in Combination With Radiation Therapy in Patients With Brain Metastases From HER2-Positive Breast Cancer

NCT00470847

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 3

Therapeutic Areas

Central Nervous System Metastases 1
HER2-positive Metastatic Breast Cancer 1

How the Nancy Lin, MD early-phase archive is shaped

4 indexed studies, none listed as recruiting (0% open); 2 completed (50%).

Phase mix: 0 late (III/IV) vs 4 early (I/II) (early-phase heavy).

Top condition: Central Nervous System Metastases (1 trial), 1 other listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Nancy Lin, MD: archived-pipeline peers nationwide

Peers matched on 4 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Nancy Lin, MD sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%20%40%60%80% Total trials Recruiting share Nancy Lin, MD4D pharma60 Degrees PharmaceuticalsA2 BiotherapeuticsAbdul Latif Jameel Poverty Action Lab10xBio22nd Century Group23andMe3-C Institute for Social Development
Nancy Lin, MD sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Nancy Lin, MD sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 4 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Nancy Lin, MD page

4 registered trials is a research-attention snapshot, not an endorsement of Nancy Lin, MD or any single study.

  • None of Nancy Lin, MD's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Central Nervous System Metastases is the condition Nancy Lin, MD studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Central Nervous System Metastases trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Nancy Lin, MD pipeline card: 4 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.